Ind-Swift Laboratories Ltd. (INDSWFTLA): Ind-Swift Laboratories Share Price Near 52-Week High After Rs 408.90 Trade

Ind-Swift Laboratories Share Price is Rs 408.90, up 0.95% today, and trading near its 52-week high with a market capitalisation of Rs 3,529.77 crore as of 24 September 2026 at 10:18 AM IST. The move keeps Ind-Swift Laboratories Ltd. (INDSWFTLA) in focus in Stock Market Today and among Stocks in News because the latest Univest figures show the stock is positioned close to its yearly high while the broader update remains rooted in verified market data. What the numbers confirm is a near-high price event, not a company-specific catalyst. Investors tracking Ind-Swift Laboratories Share Price Today will also note that the healthcare name is being watched alongside its valuation and sector context on Univest.

Ind-Swift Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 408.9
Previous Close	Rs 405.05
Today's Move	+Rs 3.85 (+0.95%)
Open	Rs 404
High	Rs 419.05
Low	Rs 400
Turnover	Rs 1.03 crore
Market Capitalisation	Rs 3,529.77 crore

Ind-Swift Laboratories Ltd. (INDSWFTLA) traded at Rs 408.9 versus the previous close of Rs 405.05, a rise of 0.95%. The stock opened at Rs 404, reached a high of Rs 419.05 and touched a low of Rs 400.

Ind-Swift Laboratories Share Price today moved from a previous close of Rs 405.05 to Rs 408.90, a gain of Rs 3.85. The stock opened at Rs 404 and moved between Rs 400 and Rs 419.05 during the current session. Turnover stood at Rs 1.03 crore, which provides a factual snapshot of traded value for the day. The current price is close to the 52-week high zone, so the stock continues to feature in 52 Week High Stocks and Market Movers searches. For readers following Ind-Swift Laboratories Stock News or Ind-Swift Laboratories Share Price Live on Univest, the key point is simple: the price action confirms a near-yearly-high event, while the latest Univest figures do not establish a company-specific reason. On Univest, this keeps Ind-Swift Laboratories Share Price in active watch mode for the current session.

Ind-Swift Laboratories Ltd. (INDSWFTLA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 3,529.77 crore
P/E Ratio	61.45x
P/B Ratio	2.5x
ROE	3.47%
ROCE	4%
EPS	Rs 6.59
Book Value Per Share	Rs 161.89
Dividend Yield	0%

Ind-Swift Laboratories Ltd. (INDSWFTLA) fundamental metrics show P/E 61.45x, P/B 2.5x, ROE 3.47%, ROCE 4%. These figures provide context only and are not a buy or sell signal.

Ind-Swift Laboratories Ltd. has a market capitalisation of Rs 3529.77 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 61.45x, P/B at 2.5x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 3.47% and ROCE of 4%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 6.59, book value per share of Rs 161.89, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.31x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	61.45x
Benchmark Median P/E	28.31x
Benchmark Average P/E	42.16x
Benchmark P/E Range	0x to 762.66x
Company P/B Ratio	2.5x
Benchmark Median P/B	3x
Company ROE	3.47%
Benchmark Median ROE	11.7%
Company ROCE	4%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 3,529.77 crore
Benchmark Median Market Cap	Rs 745.38 crore

Ind-Swift Laboratories Ltd. (INDSWFTLA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Ind-Swift Laboratories Ltd. (INDSWFTLA) has a P/E ratio of 61.45x, which is above the benchmark median of 28.31x, a difference of +117.06%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Ind-Swift Laboratories Ltd. (INDSWFTLA) has a ROE of 3.47%, which is below the benchmark median of 11.7%, a difference of -70.34%. Ind-Swift Laboratories Ltd. (INDSWFTLA) has a ROCE of 4%, which is below the benchmark median of 13.61%, a difference of -70.61%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Solara Active Pharma Sciences Ltd.	SOLARA	3,594.18	0	2.75	-0.63	4.61
Advanced Enzyme Technologies Ltd.	ADVENZYMES	3,324.01	20.05	2	11.43	15.27
Unichem Laboratories Ltd.	UNICHEMLAB	3,764.24	13.24	1.47	9.81	10.68
Aarti Drugs Ltd.	AARTIDRUGS	3,888.1	20.83	2.49	13.36	12.04
Kwality Pharmaceuticals Ltd.	KPL	3,893.25	47.69	10.84	22.67	24.01

Ind-Swift Laboratories Ltd. (INDSWFTLA) has a P/E ratio of 61.45x compared with the displayed peer median of 20.05x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 3.47% compares with a peer median of 11.43% across the companies shown in the table. ROCE stood at 4% versus the displayed peer median of 12.04%, providing a capital-efficiency comparison. Ind-Swift Laboratories Ltd. (INDSWFTLA) has a market capitalisation of Rs 3,529.77 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Ind-Swift Laboratories

• Ind-Swift Laboratories Share Price is Rs 408.90, up 0.95% from the previous close of Rs 405.05.
• The stock is trading near its 52-week high, keeping Ind-Swift Laboratories Share Price in the yearly high category.
• Market capitalisation stands at Rs 3,529.77 crore, placing the company above the industry median market cap.
• P/E is 61.45, which is above the same-industry median of 28.31 and average of 42.16.
• Revenue for June 2026 is Rs 1,914.54 crore and net profit for June 2026 is Rs 246.84 crore.

About Ind-Swift Laboratories

Ind-Swift Laboratories Ltd. is part of the Pharmaceuticals & Drugs industry in the Healthcare sector. The company operates within the same-industry universe used in the Univest sector snapshot and is tracked on NSE and BSE under INDSWFTLA. For readers following Ind-Swift Laboratories Share Price, the company profile matters mainly because the current update is being read alongside the sector classification, market capitalisation and valuation numbers. That makes the stock relevant for Ind-Swift Laboratories Latest News and Ind-Swift Laboratories Company News searches on Univest.

Frequently Asked Questions

Why is Ind-Swift Laboratories Share Price in focus today?

Ans. Ind-Swift Laboratories Share Price is in focus because it is trading near its 52-week high at Rs 408.90, up 0.95% from the previous close. The market cap is Rs 3,529.77 crore.

What is Ind-Swift Laboratories Share Price today?

Ans. Ind-Swift Laboratories Share Price today is Rs 408.90. It moved above the previous close of Rs 405.05 and traded between Rs 400 and Rs 419.05 during the current session.

How much did Ind-Swift Laboratories Share Price change today?

Ans. Ind-Swift Laboratories Share Price gained Rs 3.85, which is 0.95% over the previous close. That keeps the stock near its one-year high zone in the latest Univest update.

What does the 52-week high update mean for Ind-Swift Laboratories Share Price?

Ans. The 52-week high update means the stock is trading close to its yearly peak, not that it has broken a new record. It is a price-location event that invites attention to valuation and sector context.

Is Ind-Swift Laboratories Share Price expensive on valuation?

Ans. Ind-Swift Laboratories Share Price is linked to a P/E of 61.45, above the same-industry median of 28.31 and average of 42.16. Its P/B of 2.5 is below the industry median of 3.

What fundamentals matter for Ind-Swift Laboratories Share Price?

Ans. Key fundamentals include market cap of Rs 3,529.77 crore, EPS of 6.59, book value of 161.89, ROE of 3.47% and ROCE of 4%. Revenue for June 2026 was Rs 1,914.54 crore.

How does Ind-Swift Laboratories compare with peers?

Ans. Compared with peers such as Advanced Enzyme Technologies, Unichem Laboratories and Aarti Drugs, Ind-Swift Laboratories Share Price sits on a higher earnings multiple, while its ROE and ROCE are below several peer figures.

Where can investors track Ind-Swift Laboratories Share Price?

Ans. Investors can track Ind-Swift Laboratories Share Price on Univest for live market updates, 52-week levels, valuation ratios, sector comparison and company news. The platform keeps the stock summary in one place for quick review.

Track Ind-Swift Laboratories Share Price on Univest

Use Ind-Swift Laboratories Ltd. (INDSWFTLA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Ind-Swift Laboratories Share Price on Univest for live price updates, market cap, financial ratios, 52-week levels, sector context and peer comparison. Univest also brings together Ind-Swift Laboratories Share Price Today, Ind-Swift Laboratories Stock News and Ind-Swift Laboratories Share Price Update in one place for quick monitoring.